Hoppa till innehåll
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Språk
Alla fält
Titel
Upphovsman
Ämne
Signum
ISBN/ISSN
Tagg
Sök
Avancerad
Lenalidomide selectively inhib...
Hänvisa
Textmeddelande
Skicka per e-post
Skriv ut
Exportera posten
Exportera till: RefWorks
Exportera till: EndNoteWeb
Exportera till: EndNote
Permanent länk
Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
Bibliografiska uppgifter
Huvudupphovsmän:
Jadersten, M
,
Pellagatti, A
,
Forsblom, A
,
Emanuelsson, E
,
Merup, M
,
Samuelsson, J
,
Wainscoat, J
,
Boultwood, J
,
Hellstorm-Lindberg, E
Materialtyp:
Conference item
Publicerad:
2005
Beståndsuppgifter
Beskrivning
Liknande verk
Katalogiseringsuppgifter
Beskrivning
Sammanfattning:
Liknande verk
Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion.
av: Pellagatti, A, et al.
Publicerad: (2006)
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
av: Pellagatti, A, et al.
Publicerad: (2007)
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression.
av: Jädersten, M, et al.
Publicerad: (2009)
Del(5q) Myelodysplastic Stem Cells Exhibit Their Clonal Advantage Via Increased Adhesion to the Microenvironment
av: Scharenberg, C, et al.
Publicerad: (2011)
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression
av: Martin Jädersten, et al.
Publicerad: (2009-12-01)